Release
Oslo, 24 February 2021: Reference is made to the stock exchange notice from 4 January 2021 regarding granting of share options to leading employees. Today, as part of the same grant, a total of 32,999 share options were granted to leading employees. Primary insider Jarl Kosberg, who was appointed EVP Hydropower Project Development from 29 January 2021, was granted a total of 12,854 share options. As of 24 February 2021, Jarl Kosberg holds a total of 12,854 share options and no shares in Scatec ASA.
Each share option gives the right to subscribe for and be allotted one share in Scatec ASA. The strike price of the options is set to NOK 314.91 per share, which is the same as for the options granted 4 January 2021, based on the volume weighted average share price over the ten last trading days preceding 4 January 2021. The options will lapse if not exercised by 1 January 2025. The option grant is divided into three tranches whereby 1/3 vests each year over three years, with the first tranche vesting 1 January 2022. The current grant is the second of three contemplated annual grants of share options in accordance with Scatec's share-based incentive programme.
For further information, please contact:
Ingrid Aarsnes, VP Communication & IR, tel: +47 950 38 364, email: ingrid.aarsnes@scatec.com
About Scatec ASA
Scatec is a leading renewable power producer, delivering affordable and clean energy worldwide. As a long- term player, Scatec develops, builds, owns and operates solar, wind and hydro power plants and storage solutions. The company recently acquired SN Power, a leading hydro power developer and IPP. In first half of 2021, Scatec will have a total of 3.3 GW in operation on four continents and 485 employees. Scatec is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol ‘SCATC’. To learn more, visit www.scatec.com, or connect with us on Linkedin.
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S17.9.2025 23:05:02 CEST | Press release
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
Biogen Inc.17.9.2025 22:30:05 CEST | Press release
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
Atico Mining Corporation17.9.2025 22:30:00 CEST | Press release
Atico Signs the Investment Protection Agreement with Government of Ecuador for its La Plata Project
Frontline plc.17.9.2025 22:06:51 CEST | Press release
FRO – Filing of Half Yearly Report
VCI Global Limited17.9.2025 21:00:00 CEST | Press release
VCI Global Initiates Rescission and Cancellation of Shares from QuantGold Transaction, Tightening Capital Structure Following Reverse Split
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom